Johns Hopkins Quadrupled Its Bridge Fund To $60 Million A Year And Eliminated The Department Match: What The Research Resilience Fund Signals About Universities Becoming Insurers Of Last Resort For Federal Grants

The Johns Hopkins announcement on June 3 was framed in cautious language. The university would "expand supports for researchers affected by shifts in the federal funding landscape." It would build on a program — the Pivot and Bridge Program — that had been in place since April 2025. It would draw on "budgetary reallocation, including savings achieved through cost-reduction measures," along with $8.5 million in research funding from the State of Maryland. The new vehicle would be called the Research Resilience Fund. The word "resilience" did most of the rhetorical work.

The numbers tell a sharper story. The previous Pivot and Bridge Program was capitalized at $12.5 million annually. The Research Resilience Fund is capitalized at $60 million annually for two years — a 4.8x expansion. The previous program made 42 awards in its first year. The new program raises the per-award cap to $250,000, eliminates the divisional or departmental matching requirement that had constrained access, and explicitly covers salary expenses in addition to research project costs. The expansion was paired with a statement from President Ron Daniels acknowledging the obvious limit on what any university can do alone: "We know it is not possible to make up fully the scale of federal research funding traditionally received at Hopkins."

The context in which Hopkins made the announcement is captured in three numbers the university released alongside the program: a 43% year-over-year decline in federal research funding received, a 28% reduction in the number of federal research awards received, and a $500 million decline in the value of the university's multiyear federal research portfolio. These are not projections. They are 2025 actuals. Hopkins has historically received more federal research funding than any other U.S. university — it received $3.3 billion in federal research awards in 2024, more than three times the volume of the second-place institution. A 43% reduction in that figure represents the largest single-year contraction of federally-funded research at the country's largest federal research recipient in the post–World War II history of American science.

This piece works through what the Research Resilience Fund actually does, what gap it is attempting to fill, why the structural shift it represents matters for principal investigators at every research-intensive institution, and what specific actions PIs and grant administrators should be taking between now and the October 1 effective date of the proposed Uniform Guidance rewrite — a date by which the framework that has historically governed federal research awards will have been replaced by a framework in which agencies can terminate awards at will.

What the Pivot and Bridge Program did, and what it could not do

The Pivot and Bridge Program that Hopkins launched in April 2025 was a conventional university bridge fund. Bridge funds at research universities have existed for decades. They typically operate as small pools — $2 million to $10 million at most institutions — that provide short-term salary and supply support to PIs whose federal grants have lapsed and whose renewal applications are pending. The implicit assumption underlying bridge funds is that the gap between grants is short, that the renewal is likely to come through, and that the institution's role is to smooth a temporary cash flow problem rather than to substitute for the federal funding itself.

Hopkins's Pivot and Bridge Program was sized to that traditional assumption. $12.5 million spread across a research enterprise with $3.3 billion in federal awards represents 0.38% of the federal research base — adequate cash-flow smoothing, inadequate substitution. The program made 42 awards in its first year. With the per-award cap at the previous level — typical bridge funds at research universities cap at $50,000 to $100,000 — those 42 awards likely represented near-total exhaustion of available resources.

The expansion to $60 million annually reflects a different assumption. $60 million represents 1.8% of Hopkins's 2024 federal research base — small in absolute terms, but materially different from a cash-flow smoothing tool. At a per-award cap of $250,000, the new program can fund a postdoc plus partial PI salary plus consumables for a year, which is the actual cost structure of a single-investigator wet-lab research program. The elimination of departmental matching is the most consequential structural change: matching requirements have historically functioned to ration bridge funding by forcing departments to commit scarce flexible dollars before a PI could access the central pool. Removing the match converts the fund from a rationed resource into a more broadly accessible one, which is what is required when the gap being bridged is no longer a 12-month renewal lag but an open-ended question about whether the federal program will continue to exist.

The structural shift: universities as insurers of last resort

The traditional model of federal research funding implicitly treated the federal government as the insurer of research continuity. Multi-year award structures, renewal pathways, and a peer-review system that prized continuity of productive research programs combined to give PIs a high probability of sustained funding across decades-long careers. Bridge funds at universities existed to handle the residual variance — the unlucky renewal cycle, the program officer transition, the month-long delay between obligation and payment. The federal commitment was the insurance; the bridge fund handled the deductible.

The terminations of 2025 broke that model. The Trump administration's first-term grant terminations targeted between $6.9 billion and $8.2 billion in obligated awards, with between $3.3 billion and $3.7 billion in unspent portions actually reclaimed. Land-grant universities, HBCUs, and large private research universities have all been affected. The proposed Uniform Guidance rewrite published on May 29 — under which agencies will be permitted to terminate awards whenever an agency determines termination is "in the interest of the federal agency," including when an award no longer advances "agency priorities or the national interest as they exist at the time of the termination" — formalizes the discretion that has been exercised over the past 18 months. The federal commitment that historically functioned as insurance has been re-priced. PIs cannot assume their multi-year awards will run through their stated end dates.

In that environment, the institution-level bridge fund stops being the deductible on federal insurance and starts becoming the primary insurance itself. Hopkins's expansion to $60 million annually is the first publicly-announced institutional commitment at a scale that begins to acknowledge the new role. Other research universities — including those with smaller endowments and smaller flexible funding pools — will face pressure to follow, and most will be unable to match the scale. Hopkins's endowment, valued at roughly $13.1 billion at the end of FY2025, is large but not extraordinary. Universities with endowments under $5 billion will struggle to capitalize comparable funds. Universities with endowments under $1 billion — which includes the majority of public R1 institutions — will not be able to do it at all.

The downstream effect will be a concentration of federally-funded research at well-endowed private institutions and at large state systems whose flagship campuses can subsidize researchers across the system. Land-grant universities without large endowments, HBCUs, and smaller R1 publics will be disproportionately exposed to termination risk. The geography of American research will narrow.

What the Maryland $8.5 million tells you about the state role

The Hopkins announcement noted that $8.5 million of the $60 million annual fund comes from the State of Maryland. The state contribution is small in absolute terms but structurally significant. It establishes a precedent — that states can and should backstop research universities when federal commitments are uncertain — that other states with major research universities will face pressure to match. Massachusetts, California, Texas, North Carolina, Michigan, and Wisconsin all have flagship public research universities that are similarly exposed. Pennsylvania, Illinois, New York, and Washington each have multiple R1 institutions in similar positions.

A coordinated state response would change the cost structure of federal-grant uncertainty in ways the federal government may not have intended. If state legislatures decide that protecting their research universities is a sufficiently high priority — for the workforce pipeline, the local economy, and the prestige that flagship research universities generate — states could capitalize their own research-resilience funds at scale. The political economy of higher-education funding would shift. Universities would become less dependent on federal awards and more dependent on state appropriations. The federal-state balance in research funding, which has tilted heavily federal since World War II, would tilt back toward states.

That outcome is not assured. Most states do not have the fiscal capacity to capitalize research-resilience funds at the scale Hopkins is contemplating. Maryland's $8.5 million represents 0.014% of Maryland's FY2026 general fund — a token contribution that demonstrates the political possibility without testing the fiscal one. A serious state-level commitment to research resilience would require commitments two orders of magnitude larger from larger states, and most state legislatures have not signaled willingness to make those commitments.

What PIs and grant administrators should do now

Three specific actions follow from the Hopkins announcement and the broader pattern it indicates.

Document the institutional bridge funding picture at your institution. If your university has not announced an expanded bridge or resilience fund as of June 2026, ask your vice president for research what is available, what the per-award caps are, what eligibility criteria apply, and whether matching is required. The answer determines what fallback options exist if a federal award is terminated. PIs who learn this information before a termination occurs will be in a meaningfully better position than those who learn it during the 30-day notice window.

Build a 6-month operating budget that does not assume federal continuation. For any multi-year federal award currently active, model what happens if the award is terminated at the end of the current budget period rather than at the end of the project period. Identify which staff would need to be terminated, which experiments would need to be paused, and which consumable purchases would need to be canceled. PIs who have done this modeling can respond to a termination notice with a coherent decompression plan rather than improvising. The exercise also identifies which research lines have alternative funding paths — foundation funding, industry partnerships, internal bridge funding — and which do not.

Diversify funding sources before the termination, not after. Foundation funders, industry-sponsored research, and state-level R&D programs are not direct substitutes for federal awards, but they reduce the institutional consequences of a federal termination. PIs whose research portfolios include 20% to 30% non-federal funding have substantially more flexibility when a federal award is terminated than PIs whose portfolios are 95% federal. Building diversification takes 18 to 36 months of sustained business development effort, which is why the work has to start before a termination occurs.

The Research Resilience Fund is one institution's response to a federal funding environment that has shifted faster than the institutional infrastructure designed to absorb federal-funding variance was built to handle. It signals what other research universities are likely to attempt, what the financial limits of that response will be, and what individual researchers should be doing to protect their work. The substitution will be incomplete. The transition will be uneven. The institutions that move first will protect more of their research enterprises than the institutions that wait.